The expression of immunohistochemical biomarkers PAX8 and CD117 in platinum resistant ovarian cancer at Saiful Anwar General Hospital, Malang, Indonesia

HIGHLIGHTS • Ovarian cancer is a gynecological disease commonly encountered by women, and resistance to platinum therapy is a significant challenge in its management • PAX8 and CD117 have shown potential as predictors of resistance in ovarian cancer. However, research on the expression of these b...

Full description

Saved in:
Bibliographic Details
Main Authors: Robby Rinaldi Widodo, Tatit Nurseta, Edy Mustofa, Onni Dwi Arianto, R. A. Rose Khasana Dewi
Format: Article
Language:English
Published: Universitas Airlangga 2025-04-01
Series:Majalah Obstetri dan Ginekologi
Subjects:
Online Access:https://e-journal.unair.ac.id/MOG/article/view/52881
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849733834075013120
author Robby Rinaldi Widodo
Tatit Nurseta
Edy Mustofa
Onni Dwi Arianto
R. A. Rose Khasana Dewi
author_facet Robby Rinaldi Widodo
Tatit Nurseta
Edy Mustofa
Onni Dwi Arianto
R. A. Rose Khasana Dewi
author_sort Robby Rinaldi Widodo
collection DOAJ
description HIGHLIGHTS • Ovarian cancer is a gynecological disease commonly encountered by women, and resistance to platinum therapy is a significant challenge in its management • PAX8 and CD117 have shown potential as predictors of resistance in ovarian cancer. However, research on the expression of these biomarkers concerning platinum resistance in ovarian cancer patients. • The objective of this research is to assess the immunohistochemistry expression of CD117 and PAX8 in ovarian cancer and determine whether these expressions are linked to the development of platinum resistance.   ABSTRACT Objective: Ovarian cancer is a gynecological disease commonly encountered by women, and resistance to platinum therapy is a significant challenge in its management. This study aims explore a monitoring method for post-operative ovarian carcinoma also evaluate the immunohistochemical expression of PAX8 and CD117 in ovarian cancer and identify their association with the occurrence of platinum resistance. Materials and Methods: A cross-sectional approach to an observational analytical design, utilizing consecutive sampling which have met the inclusion and exclusion criteria. Tissue resulting from biopsy/surgical procedure which was made into a representative paraffin block was then subjected to immuno-histochemical examination in the Anatomical Pathology Department of Saiful Anwar Hospital Malang. PAX8 and CD117 expressions were analyzed using immunohistochemistry. The results of this study were assessed using ROC curves accompanied by Youden index calculation, determining sensitivity and specificity levels. Results: In this research, the results were obtained that the area under the curve (AUC) for PAX8 and CD117 is 0.785 and 0.809, respectively. PAX8 expression demonstrates the positive predictive value, negative predictive value, sensitivity, specificity, and accuracy of 53.125%, 87.50%, 18.75%, 51.85%, and 60.0%, respectively. The expression of CD117 displays the following values: 71.4 percent, 72.73%, 70%, 72.73%, and 70% for the positive predictive value, negative predictive value, sensitivity, specificity, and accuracy, respectively. Conclusion: According to this study, PAX8 and CD117 immunohistochemistry expression in ovarian cancer may act as prognostic biomarkers for platinum resistance. In this study there are several limitations that can be revised in future research.
format Article
id doaj-art-65e4e3953b3b4457b3e582bc8ebe54c3
institution DOAJ
issn 0854-0381
2598-1013
language English
publishDate 2025-04-01
publisher Universitas Airlangga
record_format Article
series Majalah Obstetri dan Ginekologi
spelling doaj-art-65e4e3953b3b4457b3e582bc8ebe54c32025-08-20T03:07:57ZengUniversitas AirlanggaMajalah Obstetri dan Ginekologi0854-03812598-10132025-04-0133111010.20473/mog.V33I12025.1-1051042The expression of immunohistochemical biomarkers PAX8 and CD117 in platinum resistant ovarian cancer at Saiful Anwar General Hospital, Malang, IndonesiaRobby Rinaldi Widodo0https://orcid.org/0009-0000-8664-5368Tatit Nurseta1https://orcid.org/0000-0001-7477-5181Edy Mustofa2https://orcid.org/0000-0002-4197-3250Onni Dwi Arianto3https://orcid.org/0009-0007-8694-246XR. A. Rose Khasana Dewi4https://orcid.org/0000-0001-6681-4216Department of Obstetrics and Gynecology, Faculty of Medicine, Brawijaya University, MalangDepartment of Obstetrics and Gynecology, Faculty of Medicine, Brawijaya University, MalangDepartment of Obstetrics and Gynecology, Faculty of Medicine, Brawijaya University, MalangDepartment of Obstetrics and Gynecology, Faculty of Medicine, Brawijaya University, MalangDepartment of Anatomic Pathology, Faculty of Medicine, Brawijaya University, MalangHIGHLIGHTS • Ovarian cancer is a gynecological disease commonly encountered by women, and resistance to platinum therapy is a significant challenge in its management • PAX8 and CD117 have shown potential as predictors of resistance in ovarian cancer. However, research on the expression of these biomarkers concerning platinum resistance in ovarian cancer patients. • The objective of this research is to assess the immunohistochemistry expression of CD117 and PAX8 in ovarian cancer and determine whether these expressions are linked to the development of platinum resistance.   ABSTRACT Objective: Ovarian cancer is a gynecological disease commonly encountered by women, and resistance to platinum therapy is a significant challenge in its management. This study aims explore a monitoring method for post-operative ovarian carcinoma also evaluate the immunohistochemical expression of PAX8 and CD117 in ovarian cancer and identify their association with the occurrence of platinum resistance. Materials and Methods: A cross-sectional approach to an observational analytical design, utilizing consecutive sampling which have met the inclusion and exclusion criteria. Tissue resulting from biopsy/surgical procedure which was made into a representative paraffin block was then subjected to immuno-histochemical examination in the Anatomical Pathology Department of Saiful Anwar Hospital Malang. PAX8 and CD117 expressions were analyzed using immunohistochemistry. The results of this study were assessed using ROC curves accompanied by Youden index calculation, determining sensitivity and specificity levels. Results: In this research, the results were obtained that the area under the curve (AUC) for PAX8 and CD117 is 0.785 and 0.809, respectively. PAX8 expression demonstrates the positive predictive value, negative predictive value, sensitivity, specificity, and accuracy of 53.125%, 87.50%, 18.75%, 51.85%, and 60.0%, respectively. The expression of CD117 displays the following values: 71.4 percent, 72.73%, 70%, 72.73%, and 70% for the positive predictive value, negative predictive value, sensitivity, specificity, and accuracy, respectively. Conclusion: According to this study, PAX8 and CD117 immunohistochemistry expression in ovarian cancer may act as prognostic biomarkers for platinum resistance. In this study there are several limitations that can be revised in future research.https://e-journal.unair.ac.id/MOG/article/view/52881ovarian cancerpax8cd117platinum resistancematernal health
spellingShingle Robby Rinaldi Widodo
Tatit Nurseta
Edy Mustofa
Onni Dwi Arianto
R. A. Rose Khasana Dewi
The expression of immunohistochemical biomarkers PAX8 and CD117 in platinum resistant ovarian cancer at Saiful Anwar General Hospital, Malang, Indonesia
Majalah Obstetri dan Ginekologi
ovarian cancer
pax8
cd117
platinum resistance
maternal health
title The expression of immunohistochemical biomarkers PAX8 and CD117 in platinum resistant ovarian cancer at Saiful Anwar General Hospital, Malang, Indonesia
title_full The expression of immunohistochemical biomarkers PAX8 and CD117 in platinum resistant ovarian cancer at Saiful Anwar General Hospital, Malang, Indonesia
title_fullStr The expression of immunohistochemical biomarkers PAX8 and CD117 in platinum resistant ovarian cancer at Saiful Anwar General Hospital, Malang, Indonesia
title_full_unstemmed The expression of immunohistochemical biomarkers PAX8 and CD117 in platinum resistant ovarian cancer at Saiful Anwar General Hospital, Malang, Indonesia
title_short The expression of immunohistochemical biomarkers PAX8 and CD117 in platinum resistant ovarian cancer at Saiful Anwar General Hospital, Malang, Indonesia
title_sort expression of immunohistochemical biomarkers pax8 and cd117 in platinum resistant ovarian cancer at saiful anwar general hospital malang indonesia
topic ovarian cancer
pax8
cd117
platinum resistance
maternal health
url https://e-journal.unair.ac.id/MOG/article/view/52881
work_keys_str_mv AT robbyrinaldiwidodo theexpressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia
AT tatitnurseta theexpressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia
AT edymustofa theexpressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia
AT onnidwiarianto theexpressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia
AT rarosekhasanadewi theexpressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia
AT robbyrinaldiwidodo expressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia
AT tatitnurseta expressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia
AT edymustofa expressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia
AT onnidwiarianto expressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia
AT rarosekhasanadewi expressionofimmunohistochemicalbiomarkerspax8andcd117inplatinumresistantovariancanceratsaifulanwargeneralhospitalmalangindonesia